These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25335224)

  • 1. Drug-induced toxic epidermal necrolysis--described in 1887.
    Schneider A; Helmstädter A
    Pharm Hist (Lond); 2014 Sep; 44(3):54-6. PubMed ID: 25335224
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic epidermal necrolysis (TEN; Ritter's disease) and staphylococcal scalded skin syndrome (SSSS). A description and review.
    Koblenzer PJ
    Clin Pediatr (Phila); 1976 Aug; 15(8):724-30. PubMed ID: 780034
    [No Abstract]   [Full Text] [Related]  

  • 3. The evil of the unknown--risk-benefit evaluation of new synthetic drugs in the 19th century.
    Schneider A; Helmstädter A
    Pharmazie; 2015 Jan; 70(1):60-3. PubMed ID: 25975100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Idiopathic Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Related to Drugs in Food? The Example of Phenylbutazone.
    Haddad C; Chosidow O; Valeyrie-Allanore L; Ghaleh B; Legrand T; Mockenhaupt M; Barau C; Khoudour N; Sekula P; Wolkenstein P; Hulin A
    J Invest Dermatol; 2017 May; 137(5):1179-1181. PubMed ID: 28108296
    [No Abstract]   [Full Text] [Related]  

  • 6. Stevens-Johnson syndrome/toxic epidermal necrolysis induced by pirfenidone.
    de Perosanz-Lobo D; Fernández-Nieto D; Burgos-Blasco P; Aroca-Ruiz M; Fernández-Guarino M
    Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):542-544. PubMed ID: 34114417
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toxic epidermal necrolysis and celecoxib (Celebrex)].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2004 Jan; 131(1 Pt 1):107. PubMed ID: 15041861
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxic epidermal necrolysis associated with indomethacin therapy.
    Lear JT; English JS
    Postgrad Med J; 1996 Mar; 72(845):186-7. PubMed ID: 8731717
    [No Abstract]   [Full Text] [Related]  

  • 11. 100 years of pyrazolone drugs.
    Schadewaldt H
    Agents Actions Suppl; 1986; 19():341-55. PubMed ID: 3529886
    [No Abstract]   [Full Text] [Related]  

  • 12. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Roujeau JC; Kelly JP; Naldi L; Rzany B; Stern RS; Anderson T; Auquier A; Bastuji-Garin S; Correia O; Locati F
    N Engl J Med; 1995 Dec; 333(24):1600-7. PubMed ID: 7477195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
    Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
    Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylsalicylic acid and other salicylates in relation to Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Kaufman DW; Kelly JP
    Br J Clin Pharmacol; 2001 Feb; 51(2):174-6. PubMed ID: 11259991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic epidermal necrolysis following treatment with oxaprozin.
    Carucci JA; Cohen DE
    Int J Dermatol; 1999 Mar; 38(3):233-4. PubMed ID: 10208628
    [No Abstract]   [Full Text] [Related]  

  • 16. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lyell's syndrome--possibly drug-induced epidermal necrolysis in a 7-year-old boy].
    Balcar-Boroń A; Smukalska E; Nowaczyk-Michalak A; Wysocki M; Przybysz-Gebska I
    Wiad Lek; 1990 Oct 1-15; 43(19-20):988-91. PubMed ID: 2075745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective.
    Mockenhaupt M; Kelly JP; Kaufman D; Stern RS;
    J Rheumatol; 2003 Oct; 30(10):2234-40. PubMed ID: 14528522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Induced by Fexofenadine.
    Teo SL; Santosa A; Bigliardi PL
    J Investig Allergol Clin Immunol; 2017 Jun; 27(3):191-193. PubMed ID: 28570227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.